Literature DB >> 34292295

Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.

Kristin A Robinson1, Santo Maimone1, Denise A Gococo-Benore2, Zhuo Li3, Pooja P Advani4, Saranya Chumsri4.   

Abstract

Entities:  

Year:  2021        PMID： 34292295     DOI： 10.1001/jamaoncol.2021.3127

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  10 in total

Review 1.  Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination.

Authors:  Stacey Wolfson; Eric Kim
Journal:  Radiology       Date:  2022-10-11       Impact factor: 29.146

Review 2.  Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.

Authors:  Francisco Pimentel Cavalcante; Edson Abdala; Leonardo Weissmann; Carlos Eduardo Dos Santos Ferreira; Gilberto Amorim; Vilmar Marques de Oliveira; Gisah Guilgen; Luciana Landeiro; João Renato Rebello Pinho; Álvaro Pulchinelli; Heber Ribeiro; Rafael Souza; Daniela Dornelles Rosa
Journal:  JCO Glob Oncol       Date:  2022-05

3.  US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.

Authors:  Su Min Ha; A Jung Chu; JungBok Lee; Soo-Yeon Kim; Su Hyun Lee; Heera Yoen; Nariya Cho; Woo Kyung Moon; Jung Min Chang
Journal:  Radiology       Date:  2022-04-26       Impact factor: 29.146

4.  Frequency and Outcomes of Ipsilateral Axillary Lymphadenopathy After COVID-19 Vaccination.

Authors:  Wenhui Zhou; Wendy B DeMartini; Debra M Ikeda
Journal:  JAMA Netw Open       Date:  2022-06-01

5.  Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study.

Authors:  Ji Yeon Park; Ji Young Lee; Seong Yoon Yi
Journal:  J Clin Med       Date:  2022-01-03       Impact factor: 4.241

Review 6.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.

Authors:  Jihe Lim; Seun Ah Lee; Eun Kyung Khil; Sun-Ju Byeon; Hee Joon Kang; Jung-Ah Choi
Journal:  Semin Oncol       Date:  2021-10-26       Impact factor: 4.929

7.  Ipsilateral Lymphadenopathy After COVID-19 Vaccination in Patients With Newly Diagnosed Breast Cancer.

Authors:  Su Min Ha; Jong-Ho Cheun; Su Hyun Lee; Soo-Yeon Kim; Ah Reum Park; Yeon Soo Kim; Heera Yoen; Youkyoung Lee; Nariya Cho; Woo Kyung Moon; Jung Min Chang
Journal:  J Breast Cancer       Date:  2021-03-03       Impact factor: 3.588

Review 8.  COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature.

Authors:  Roxanne T Aleman; Julia Rauch; Janvi Desai; Joumana T Chaiban
Journal:  Cureus       Date:  2022-07-14

9.  Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.

Authors:  Takeharu Yoshikawa; Soichiro Miki; Takahiro Nakao; Saori Koshino; Naoto Hayashi; Osamu Abe
Journal:  Radiology       Date:  2022-09-13       Impact factor: 29.146

10.  Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis.

Authors:  Shun Kawaguchi; Nobuko Tamura; Kiyo Tanaka; Yoko Kobayashi; Junichiro Sato; Keiichi Kinowaki; Masato Shiiba; Makiko Ishihara; Hidetaka Kawabata
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.